GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...

OpenProtein.AI is helping biologists stay on the cutting edge of AI with a no-code platform for protein engineering.

The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...

Finnish startup Happy Plant Protein is building a first-of-its-kind facility in Latvia to process locally grown crops into ...

In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency of early-stage molecule discovery is always the key factor determining project success ...

Scientists at the VIB–VUB Center for Structural Biology have uncovered a counterintuitive principle that could reshape how ...

Recently, a range of effective methods have been developed for predicting protein-protein interactions (PPIs). Among them, the methods based on data derived from protein sequences and structures have ...

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...

DAVIS, Calif.--(BUSINESS WIRE)--The OpenFold Consortium, a leading nonprofit artificial intelligence (AI) research consortium, today announced a preview release of OpenFold3, an open-source deep ...